Extracellular Cleavage of Microglia-Derived Progranulin Promotes Diet-Induced Obesity

Chae Beom Park1, Chan Hee Lee2, Kae Won Cho3

  • 1Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea.

Diabetes
|September 20, 2024
PubMed

Insights

Microglia-derived progranulin (PGRN) cleavage promotes obesity. Inhibiting this process may offer new therapies for diet-induced obesity by reducing hypothalamic inflammation.

Area of Science:

  • Neuroimmunology
  • Metabolic Research
  • Molecular Biology

Background:

  • Obesity pathogenesis involves hypothalamic inflammation driven by dietary fats.
  • Microglia, the brain's immune cells, are key players in this process.
  • Progranulin (PGRN) is a protein highly expressed in microglia, involved in inflammation.

Purpose of the Study:

  • To investigate the role of microglia-derived PGRN in regulating metabolism.
  • To understand how PGRN cleavage in the hypothalamus affects diet-induced obesity.

Main Methods:

  • Generation of a mouse model with microglia-specific Grn gene deletion.
  • Analysis of metabolic phenotypes under normal and high-fat diet (HFD) conditions.
  • Assessment of hypothalamic inflammation and PGRN cleavage.

Main Results:

  • Microglial Grn depletion caused hyperglycemia on a normal diet but reduced obesity and inflammation on an HFD.
  • HFD increased extracellular cleavage of anti-inflammatory PGRN into proinflammatory GRNs in the hypothalamus.
  • Inhibiting PGRN cleavage ameliorated HFD-induced hypothalamic inflammation and obesity.

Conclusions:

  • Extracellular cleavage of microglia-derived PGRN significantly promotes hypothalamic inflammation and obesity during overnutrition.
  • Targeting PGRN cleavage presents a potential therapeutic strategy for diet-induced obesity.